NKNikolay F. Krotov

Nikolay F. Krotov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nikolay F. Krotov has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Variants of the anatomy of the renal vascular bed in patients with retroperitoneal germ cell tumors

    by Eldar M. Mamizhev, Мамижев Эльдар Мухамедович, R. V. Orlova, Орлова Р. В., D. I. Rumyantseva, Румянцева Д. И., R. A. Melikov, Меликов Р. А., Z. A. Tambiyeva, Тамбиева З. А., et al.

    Background. Renovascular anatomy is characterized by complex morphological variations in relation to the number, origin level, length, diameter and topographic relationships of the vessels. Understanding of individual vascular anatomy during the planning of surgical intervention in the retroperitoneal space allows to decrease technical difficulty and achieve better perioperative results. Aim. To study frequencies of renal vessel variant anatomies that can become intraoperative finds in patients with germ cell tumors of the retroperitoneal location due to incomplete preoperative examination creating technical difficulties during surgical treatment. Materials and methods. At the first stage, comparison of a group of 407 patients with germ cell tumors with a control group (401 patients with other oncological diseases) by the presence of vascular anomalies was performed. The second stage consisted of intragroup analysis of operative time, blood loss volume and complications in patients after retroperitoneal lymph node dissection depending on the identified vascular anomaly. Results. Anomalies of renal arteries were identified in 73.2 % of cases in the germ cell tumor group which significantly differed from the control group value of 24.9 % (р = 0.001). The frequency of renal vein anomalies in germ cell tumors was 69.0 % compared to 12.5 % in the control group (р 0.05). Median operative time in the total group was 217.2 ± 0.7 min. Statistically significant differences in increase of operative time in the presence of additional arteries (р = 0.001) and veins (р = 0.002) were observed. Total mean blood loss volume was 389 ± 51.4 mL. Intraoperative blood loss volume significantly depended on injury of additional arteries (р = 0.003) and veins (р = 0.002). Intraoperative complications associated with injury of the main large vessels were observed in 18.7 % of cases. Clinically significand trend was observed towards decreased intraoperative injury of additional and main vessels (total number of injuries 36 (8.9 %) and 76 (18.7 %), respectively; р = 0.017) and, therefore, decreased risk of surgical complications after accumulation of experience in retroperitoneal lymph node dissection and introduction of computed tomography with 3D reconstruction of renal vessels in 2018. Conclusion. Frequency and diversity of various vessels of the retroperitoneal space in patients with germ cell tumors require careful preoperative preparation of the patients in the form of topographic visualization of the vascular network.

  • Open Access

    Minimally invasive retroperitoneal lymph node dissection for stage IIA/B testicular seminomatous germ cell tumors

    by Eldar M. Mamizhev, R. V. Orlova, D. I. Rumyantseva, S. A. Antonova, P. M. Gorlin, N. F. Krotov, A. K. Nosov

    Background. According to primary orchiectomy data, up to 50–60 % of testicular germ tumors are seminomas. For stage IIA and IIB seminomas, radiotherapy (RT) and polychemotherapy (PCT) are generally accepted treatment standards with excellent 5-year survival up to 99 %. Despite high treatment efficacy, PCT and RT are accompanied by significant toxic effects which can severely decrease patients’ quality of life. Aim. To evaluate efficacy and safety of retroperitoneal lymph node dissection (RPLND) as a first stage of treatment after orchiectomy as an alternative to PCT and RT. Materials and methods. In total, 24 patients with stage IIA/B testicular seminomatous germ cell tumors without RT were selected. The patients were divided into groups: in the 1st group, robot-assisted RPLND without PCT after orchiectomy was performed (n = 14); in the 2nd group, PCT per the BEP scheme (bleomycin + etoposide + cisplatin) with subsequent laparoscopic RPLND after orchiectomy was performed (n = 10). In both groups, complications per the Clavien–Dindo classification, operative time, blood loss volume, hospital days, recurrence-free survival, presence of ejaculation after RPLND, histological conclusion, PCT toxicity were assessed. Results. Mean patient age was 38 years. Patient distribution per disease stage: 18 (75.0 %) patients with stage IIA, 6 (25.0 %) patients with stage IIB. There were no intraoperative vascular complications, no transition to laparotomy. Mean operative time was 267 ± 19.4 min. Mean blood loss volume was 174 ± 25 mL. Mean hospital days were 8 days. No significant postoperative complications (severity grade ≥IV per the Clavien–Dindo classification) were reported. In the late postoperative period, 2 patients required surgical treatment for lymphorrhea in the form of transcutaneous translumbar puncture with embolization of the lymph ducts under the control of flat detector computed tomography. Mean number of resected lymph nodes was 27.1. Viable tumor was verified in 2 (8.3 %) patients of the 1st group. Functional results: retrograde ejaculation in 11 (45.8 %) cases (in group 1: 3 (21.4), in group 2: 8 (80.0); p = 0.01). Recurrence-free survival in the 1st group (2-year observation) was 13.1 ± 1.9 (9.3–16.9) months, in the 2nd group (observation from 2013 to 2025), 57 ± 5.7 (11.0–116.8) months. None of the patients had signs of recurrence per clinical, instrumental or laboratory data. Conclusion. Prophylactic RPLND decreases the risk of recurrence and progression of germ line testicular tumors and allows to avoid risks of delayed toxicity associated with PCT and RT. In patients with stage IIA/B seminomas and low volume of residual retroperitoneal masses, RPLND provides good prognosis with minimal risks of treatment continuation in the future.

  • Open Access

    Surgical risks in radical cystectomy: experience of a specialized center

    by M. V. Berkut, N. F. Krotov, A. K. Nosov

    Background. Radical cystectomy is the standard treatment for muscle invasive bladder cancer. However, it is associated with a high risk of complications and mortality. Key strategies to reduce these risks include implementation of minimally invasive treatment methods and the Enhanced Recovery After Surgery (ERAS) protocol, as well as identification of factors associated with development of complications.Aim. To analyze 30-day postoperative complications and mortality rates following radical cystectomy taking into account the effect of the ERAS protocol on treatment outcomes.Materials and methods. This retrospective single-center cohort study included surgical treatment outcomes of 455 patients with a confirmed diagnosis of bladder cancer (cTis–4N0–3) who underwent radical cystectomy via either open or laparoscopic approaches. Of these, 344 patients (75.6 %) underwent perioperative rehabilitation following the ERAS principles. The severity of complications was assessed using the Clavien classification as modified by the European Association of Urology. The study protocol was approved by the Biomedical Ethics Committee (No. 32/355 from 23.12.2020).Results. Surgeries in the ERAS group were more frequently performed using minimally invasive techniques (98.5 % vs. 62.2 %; p 0.001), with reduced blood loss and shorter operative times, and were more often accompanied by standard and extended lymphadenectomy (p 0.001). In the ERAS group, ileocecal angle mobilization was performed in 49.4 % of cases, significantly reducing the risk of mechanical and dynamic bowel obstruction by factor of 2.68 (p = 0.006). Median in-hospital time was 9 days shorter in the ERAS group (p 0.001), and overall complication rate was 40.7 % compared to 56.8 % in the standard care group (p = 0.003). Mortality rates did not differ between the groups (1.8 % vs. 2.3 %; p = 1.0).Conclusion. The implementation of the ERAS protocol and minimally invasive techniques in radical cystectomy significantly reduces postoperative complication rates, including the risk of bowel obstruction, shortens hospital stays, and improves overall treatment outcomes.

  • Open Access

    Ureteroileal anastomosis-associated complications of radical cystectomy with ileal conduit in bladder cancer treatment

    by D. I. Rumiantseva, E. M. Mamizhev, N. F. Krotov, N. А. Shchekuteev, М. Е. Карасева, D. P. Semeyko, Ya. P. Bashmakova, А. К. Носов

    Background. Radical cystectomy remains the gold standard of bladder cancer treatment for both muscle invasive form and high-risk patients. However, despite the patients’ high quality of life after radical cystectomy, formation of ureteroileal anastomoses (UIA) is still associated with a number of serious complications at various times in the postoperative period.Aim. To evaluate the effectiveness of an original technique of UIA formation in the context of development of postoperative complications.Materials and methods. At the N.N. Petrov National Medical Research Center of Oncology between January 2012 and October 2023, 465 radical cystectomies with ileal conduit were performed. In retrospective analysis, patients were divided into two groups: group 1 (n = 285) with the conventional technique for forming UIA, group 2 (n = 180) with a modified technique. Clinical and demographic characteristics of the groups were compared using t-test and χ2-test. Multivariate logistic regression analysis was performed to determine the likelihood of complications associated with UIA.Results. Both groups were matched by clinical and demographic characteristics. The overall rate of complications associated with UIA was slightly lower in group 2 than in the conventional technique group (15 % vs. 16 %; p 0.001). Late complications associated with UIA were observed significantly less in the modification group (2.7 % vs. 4.2 %; p 0.001), and in group 2 repeat surgical interventions were required significantly less often. In multivariate analysis, the modified technique group was significantly less likely to develop UIA-associated complications than the conventional technique group (odds ratio 0.123; 95 % confidence interval 0.06–0.22 vs. odds ratio 0.179; 95 % confidence interval 0.12–0.27; p 0.001).Conclusion. The presented modified technique of UIA formation can be quite effective in reducing the risk of developing UIA-associated complications.

  • Open Access

    Prevention of infectious complications after radical cystectomy: a systematic review and meta-analysis

    by M. V. Berkut, A. M. Belyaev, N. F. Krotov, O. V. Zaozerskii, A. K. Nosov

    The aim of this study was to conduct a systematic review and meta-analysis of the literature to evaluate the impact of different antibiotic prophylaxis (АР) strategies on the incidence of infectious complications within 30 days after radical cystectomy (RC).Material and Methods. The meta-analysis protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO): ID-CRD42023480525. A systematic search for studies published in the last 10 years (November 2013 – November 2023) was conducted in the PubMed and Cochrane Library databases by two independent researchers. A total of 7 full-text articles were included in the final statistical analysis (data from 90,935 patients). The analysis focused on three aspects: comparison of the effectiveness of different durations of antibiotic prophylaxis (24 hours or more), the impact of the type of antibacterial agent used, and the application of Enhanced Recovery after Surgery (ERAS) protocols on the overall incidence of infectious complications, the development of soft tissue infections, and upper urinary tract infections (UTIs). Meta-analysis was performed using R 4.3.2 (R Foundation for Statistical Computing, Vienna, Austria) and the metafor 4.2-0 package.Results. The median overall incidence of infectious complications was 31.78 % (23.8–58.8 %), surgical site infections – 16.46 % (6.25–35.41 %), and UTIs – 25.11 % (3.86–35.7 %), including cases leading to urosepsis. The meta-analysis did not reveal a statistically signifшcant effect of the duration of AP (24 hours or more) on the risk of infectious complications: for overall infectious complications, the risk was OR 1.11 (95 % CI 0.92–1.33; p=0.27), for surgical site infection OR 1.00 (95 % CI 0.87–1.15; p=0.97), and for UTIs OR 0.96 (95 % CI 0.84–1.10; p=0.59). However, the overall incidence of infectious complications was significantly higher in the standard perioperative management group, without ERAS protocols (OR=3.02 [95 % CI 2.07; 4.39], p ˂ 0.001, I2 =93.1 %).Conclusion. The results of this study indicate that existing AP strategies may be ineffective in reducing postoperative infectious complications in patients undergoing cystectomy with urinary diversion. Extending AP beyond 24 hours, as well as the standard regimen, did not demonstrate a reduction in infection risk, highlighting the need for a revision of clinical guidelines in this area. The principles of the ERAS program may play a crucial role in reducing infectious complications, showing promising results and requiring further research and implementation in clinical practice.

  • Open Access

    Efficacy and safety of negative wound pressure in the treatment of surgical complications after radical cystectomy: a retrospective cohort study

    by Mariya V. Berkut, Alexey M. Belyaev, Nikolay F. Krotov, Marina E. Karaseva, Alexander K. Nosov, Беляев Алексей Михайлович

    Background: Negative pressure wound treatment (NPWT) is a relatively new, but promising method for management of surgical site infection (SSI). The literature data on the use of NPWT for complications in oncology surgery, and after radical cystectomy (RC) in particular, is scarce. Aim: To evaluate the short-term results of NPWT dressings in the management of SSI after RC. Materials and methods: We retrospectively analyzed data from 446 patients who had RC with various uroderivation types in the Department of Oncourology of the N. N. Petrov National Medical Research Center of Oncology from January 2012 to December 2021. A total of 62 cases of SSI emerging up to day 30 after RC were identified with complete data. Thirty six (36) cases of SSI were managed according to standard procedures, and 26 patients with SSI were treated with NPWT (VivanoTec® S 042) at constant negative pressure mode. The physical condition of the patients before RC was assessed according to the American Society of Anesthesiology (ASA) classification, and the severity of the patient's condition at SSI diagnosis within APACHE II scale. The following parameters were also analyzed: body mass index, median number of days in the hospital, number of program wound sanitations (surgical debridement) or frequency of changing NPWT dressings, changes over time in C-reactive protein and leukocyte index of intoxication, and events of clinical interest (intestinal fistulas and lateralization of the median wound margins, hernias). Results: Most cases of post-RC SSIs were identified in men (57/62, 91.93%). The standard management and NPWT study groups were well balanced for age, body mass index, and ASA physical status. The median time from the first surgical debridement of the wound to its closure was significantly shorter in the standard surgical management group: 4 days (0; 8.75) versus 8.5 days (3.25; 12.0) in the NPWT group (p = 0.026). However, this did not negatively affect the length of hospitalization (28.08 ± 12.80 and 30.03 ± 16.27 days, respectively, p = 0.599). The 30-day mortality rates were not significantly different between the groups (p = 0.137). In our series with NPWT dressings, there were no cases of intestinal fistulas in the early and late postoperative periods. Conclusion: Negative pressure wound treatment is a safe and effective method of SSI management. It is not inferior to the generally accepted treatment standard with surgical wound debridement, staged sanitations or dressings. NPWT dressings allow for early primary muscular-fascial closure of the abdominal cavity and does not increase the duration of hospital stay, postoperative death rates and the risk of intestinal fistulas.

  • Open Access

    Atlantis exploration: predictive biomarkers to immunotherapy response

    by A. K. Nosov, N. F. Krotov, M. V. Berkut

    The emergence and continuous development of immune checkpoint inhibitors (ICIs) therapy brings a revolution in cancer therapy history including urothelial carcinoma. Early accurate targeting and adequate treatment are critical to patient prognosis and overall survival. To overcome these limitations, two strategies are actively being pursued: identification of predictive biomarkers for clinical response to ICIs and multi-pronged combination therapies. Biomarkers might allow clinicians to practice a precision medicine approach in ICIs (biomarkerbased patient selection). The development of predictive biomarkers is needed to optimize patient benefit, minimize risk of toxicities, and guide combination approaches.The greatest focus in clinical trials and reviews has been on tumor-cell PD-L1 expression. Although PD-L1 positivity enriches for populations with clinical benefit, PD-L1 testing alone is insufficient for patient selection in most malignancies. In this review, we discuss the status of PD-L1 testing and explore emerging data on new biomarker strategies with tumor-infiltrating lymphocytes, mutational burden, immune gene signatures, microsatellite instability and molecular subtypes.